{"schema":"hottub-news/story/v1","story":"st_ekxsvf5vhi4tjqzed5ta","title":"FDA approves pirtobrutinib for previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma","title_en":null,"outlets":3,"brief":null,"page":"https://hottub.news/stories/fda-approves-pirtobrutinib-for-previously-untreated-chronic-lymphocytic-ekxsvf5vhi","count":3,"items":[{"id":"n_oevfd6cb7dkjynprtztq","seq":1459198,"kind":"article","title":"FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL","url":"https://www.pharmacytimes.com/view/fda-approves-pirtobrutinib-for-previously-untreated-cll-sll","published":"2026-10-02T20:55:00Z","seen":"2026-10-03T01:28:11Z","lang":"en","source":{"id":"pharmacytimes.com","name":"pharmacytimes.com","domain":"pharmacytimes.com","outlet":{"wikidata":"Q27712672","name":"Pharmacy times","type":"website","designations":["scientific journal","website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q116622551","name":"pirtobrutinib","type":"other"},{"id":"Q18557229","name":"chronic lymphocytic leukemia and small lymphocytic lymphoma","type":"other"}],"story":"st_ekxsvf5vhi4tjqzed5ta","category":"health","category_p":0.5899999737739563,"sentiment":"neutral","tone":-0.17000000178813934,"political":0.15000000596046448},{"id":"n_7se7qozcqhlhzw2zoc2q","seq":1451501,"kind":"article","title":"FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL","url":"https://www.onclive.com/view/fda-approves-pirtobrutinib-for-previously-untreated-cll-sll","published":"2026-10-02T19:41:00Z","seen":"2026-10-03T00:07:08Z","lang":"en","source":{"id":"onclive.com","name":"onclive.com","domain":"onclive.com","outlet":{"wikidata":"Q140944690","name":"OncLive","type":"website","designations":["publication","website"]}},"via":"gdelt-gkg-english","topics":["economy","health","education"],"story":"st_ekxsvf5vhi4tjqzed5ta","category":"health","category_p":0.5899999737739563,"sentiment":"neutral","tone":-0.10000000149011612,"political":0.15000000596046448},{"id":"n_ekxsvf5vhi4tjqzed5ta","seq":1422504,"kind":"article","title":"FDA approves pirtobrutinib for previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma","url":"http://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pirtobrutinib-previously-untreated-chronic-lymphocytic-leukemia-or-small-lymphocytic","summary":"On October 2, 2026, the Food and Drug Administration approved pirtobrutinib (Jaypirca, Eli Lilly and Company) for adult patients with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) with no known 17p deletion.","published":"2026-10-02T19:31:02Z","seen":"2026-10-02T20:17:14Z","lang":"en","country":"US","source":{"id":"kite-fda-gov-272311","name":"fda.gov","domain":"fda.gov","outlet":{"wikidata":"Q204711","name":"United States Food and Drug Administration","type":"other","country":"US","designations":["food safety organization","united states federal agency"]}},"via":"kite-fda-gov-272311","topics":["healthcare","usa"],"authors":["FDA"],"story":"st_ekxsvf5vhi4tjqzed5ta","category":"health","category_p":0.6899999976158142,"sentiment":"neutral","tone":0.23999999463558197,"political":0.18000000715255737}]}